The following information relates to the first phase of the Consortium (‘VIMC 1.0’, from 2016-2022). A summary of our plans for our new project phase, VIMC 2.0 (2022 – 2027), can be found here.

VIMC impact estimates

Lancet publication, Jan 2021: ‘Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study’

Data visualisation tool to accompany the Lancet paper

Science Journal for Teens article: How Many Lives Do Vaccines Save?

Technical description of impact estimation methods and VIMC impact estimates (pdf)

Technical description of impact estimation methods and VIMC impact estimates (html)

Coverage clustering and indirect benefit (pdf)

VIMC standard guidance on DALYs

Consortium materials

Access Montagu (log-in required)

Consortium Summary 2017 (pdf)

Consortium Organizational Chart 2022 (pdf)

Consortium model quality standards (pdf)

Consortium frequently used acronyms (xlsx)

List of countries and antigens modelled by the Consortium (xlsx)

Clinton Health Access Initiative (CHAI)

EPIC Immunization Costing project

ImmunizationEconomics.org

International Vaccine Access Center (IVAC)

PATH

Vaccine Confidence Project

Vaccineswork.org

WHO Initiative for Vaccine Research (IVR)

Other modelling initiatives

Technical Consultation on Modelling of Hepatitis B